Evidence map›Paper›PMID 39135939›Full record

ArticleClinical kidney journal2024

Hypoaldosteronism due to a novel SEC61A1 variant successfully treated with fludrocortisone.

Diana Karpman, Martin L Lindström, Mattias Möller, Sofie Ivarsson, Ann-Charlotte Kristoffersson, Zivile Bekassy, Agnes B Fogo, Maria Elfving

Abstract read
In one paragraph

Article in Clinical kidney journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Diana KarpmanDepartment of Pediatrics, Clinical Sciences Lund, Lund University, Lund, Sweden.ORCID https://orcid.org/0000-0001-7220-7658
Martin L LindströmDepartment of Pathology, Skåne University Hospital and Regional Laboratories, Malmö, Sweden.
Mattias MöllerDivision of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden.
Sofie IvarssonDivision of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden.
Ann-Charlotte KristofferssonDepartment of Pediatrics, Clinical Sciences Lund, Lund University, Lund, Sweden.
Zivile BekassyDepartment of Pediatrics, Clinical Sciences Lund, Lund University, Lund, Sweden.
Agnes B FogoDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Maria ElfvingDepartment of Pediatrics, Clinical Sciences Lund, Lund University, Lund, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Genetic variants in Methods: A patient is described that presented at 1 year of age with failure-to-thrive, kidney failure (glomerular filtration rate, GFR, 18 ml/min/1.73m Results: The patient has a novel de novo heterozygous Conclusions: As the renin-angiotensin system promotes aldosterone release, and the patient had repeatedly undetectable aldosterone levels, the

Indexed as

autosomal dominant tubulo-interstitial kidney diseasekidneyrenal tubular dysgenesisreninSEC61A1

Identifiers

PMID39135939
PMCPMC11317836

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.